Bleakley Financial Group LLC boosted its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 242,353 shares of the company’s stock after purchasing an additional 28,838 […]